123 related articles for article (PubMed ID: 34842386)
1. Evaluation of Angiogenesis by Using CD105 and CD34 in Sudanese Breast Cancer Patients.
M Abbas A; Shalabi MG; A Elsiddig S; Eltahir Z; M A Babker A; G Ahmed H
Pak J Biol Sci; 2021 Jan; 24(11):1144-1151. PubMed ID: 34842386
[TBL] [Abstract][Full Text] [Related]
2. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
3. Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry.
Bhatia JK; Chaudhary T; Boruah D; Bharadwaj R
Med J Armed Forces India; 2022 Jul; 78(3):345-354. PubMed ID: 35855704
[TBL] [Abstract][Full Text] [Related]
4. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
Wang Y; Zhang XH; Guo P; Yan LN; He D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
[TBL] [Abstract][Full Text] [Related]
5. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
6. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
[TBL] [Abstract][Full Text] [Related]
7. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
8. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
10. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34.
Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H
Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer.
Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C
Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208
[TBL] [Abstract][Full Text] [Related]
12. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
13. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.
Mineo TC; Ambrogi V; Baldi A; Rabitti C; Bollero P; Vincenzi B; Tonini G
J Clin Pathol; 2004 Jun; 57(6):591-7. PubMed ID: 15166262
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome.
Martone T; Rosso P; Albera R; Migliaretti G; Fraire F; Pignataro L; Pruneri G; Bellone G; Cortesina G
Oral Oncol; 2005 Feb; 41(2):147-55. PubMed ID: 15695116
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
17. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
[TBL] [Abstract][Full Text] [Related]
18. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
Li Q; Zhang B; Peng P
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody.
Tanaka F; Otake Y; Yanagihara K; Kawano Y; Miyahara R; Li M; Yamada T; Hanaoka N; Inui K; Wada H
Clin Cancer Res; 2001 Nov; 7(11):3410-5. PubMed ID: 11705856
[TBL] [Abstract][Full Text] [Related]
20. Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.
Ponzoni M; Savage DG; Ferreri AJ; Pruneri G; Viale G; Servida P; Bertolini F; Orazi A
Mod Pathol; 2004 Dec; 17(12):1513-20. PubMed ID: 15272276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]